Kaufmann, Max http://orcid.org/0000-0002-1954-4425
Schaupp, Anna-Lena
Sun, Rosa http://orcid.org/0000-0002-4979-1574
Coscia, Fabian http://orcid.org/0000-0002-2244-5081
Dendrou, Calliope A.
Cortes, Adrian
Kaur, Gurman http://orcid.org/0000-0001-7722-3956
Evans, Hayley G.
Mollbrink, Annelie
Navarro, José Fernández http://orcid.org/0000-0002-4035-5258
Sonner, Jana K. http://orcid.org/0000-0002-4700-272X
Mayer, Christina
DeLuca, Gabriele C. http://orcid.org/0000-0003-0342-5197
Lundeberg, Joakim http://orcid.org/0000-0003-4313-1601
Matthews, Paul M. http://orcid.org/0000-0002-1619-8328
Attfield, Kathrine E.
Friese, Manuel A. http://orcid.org/0000-0001-6380-2420
Mann, Matthias http://orcid.org/0000-0003-1292-4799
Fugger, Lars http://orcid.org/0000-0003-2883-3226
Article History
Received: 7 January 2022
Accepted: 16 May 2022
First Online: 20 June 2022
Competing interests
: G.C.D. has received research funding from Merck Serono, travel expenses from Bayer Schering, Biogen Idec, Genzyme, Merck Serono, Novartis and honoraria as an invited speaker/faculty/advisor for Novartis and Roche. J.L. and A.M. are scientific consultants for 10X Genomics. P.M.M. has received consultancy fees from Roche, Adelphi Communications, Celgene, Neurodiem and Medscape, honoraria or speakers’ fees from Novartis and Biogen and has received research or educational funds from Biogen, Novartis and GlaxoSmithKline. The remaining authors declare no competing interests.